Trendsetting Intralogistics Expansion at Galexis with SSI Schaefer as Long-term Partner
The leading wholesaler and service provider Galexis AG ensures timely and consistent drug supply of all partners in the…
The leading wholesaler and service provider Galexis AG ensures timely and consistent drug supply of all partners in the…
Galexis AG is a leading pharmaceutical wholesaler serving the Swiss healthcare market. While currently equipped with a h…
As part of the IPO of Galenica on 7 April 2017, Jean-Claude Clémençon took over the role of CEO Galenica Group in additi…
Galenica today issued fixed-interest bonds totalling CHF 380 million for the purpose of long-term financing at attractiv…
Kalina Scott will join Polyphor as Chief Financial Officer as of June 1st, 2017. She brings over 20 years of experience…
The Galenica Group once again reported strong results in 2016. Consolidated net sales grew by 8.6% to CHF 4,118.4 millio…
Approx. 2,000 doctors currently use Swisscom Health’s curaPrax. The Swisscom subsidiary is now to double its regular cus…
Velphoro® (sucroferric oxyhydroxide) has received EU marketing authorisation from the European Commission for the contro…
. - Velphoro® (PA21) recommended for approval in the European Union for the treatment of hyperphosphatemia in adult Chr…
Although such a step will not become obligatory until 2015, the Board of Directors of Galenica Ltd. already submitted a…